Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
DBV Technologies USD 189.6M 12.3M 2026-09
Galectin Therapeutics USD 27.29M 1.83M 2024-06
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09